(NASDAQ: STAA) Staar Surgical Co's forecast annual revenue growth rate of 18.2% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.15%.
Staar Surgical Co's revenue in 2025 is $224,449,000.On average, 12 Wall Street analysts forecast STAA's revenue for 2025 to be $12,905,592,435, with the lowest STAA revenue forecast at $12,025,530,534, and the highest STAA revenue forecast at $13,590,415,379. On average, 12 Wall Street analysts forecast STAA's revenue for 2026 to be $16,374,800,416, with the lowest STAA revenue forecast at $13,627,084,625, and the highest STAA revenue forecast at $19,397,040,020.
In 2027, STAA is forecast to generate $18,010,546,101 in revenue, with the lowest revenue forecast at $15,267,785,614 and the highest revenue forecast at $21,426,236,804.